(157 days)
No
The description focuses on computer-aided navigation using spatial tracking and measurements, with no mention of AI or ML terms or concepts.
No
Explanation: The device is a navigation platform for computer-aided surgery, providing guidance for instrument positioning during arthroplasty. It does not directly treat or prevent a disease or condition, which is characteristic of a therapeutic device.
No
Explanation: The device is a surgical navigation system that aids in the accurate positioning of surgical instruments and implants during arthroplasty, and provides intraoperative measurements. It does not diagnose diseases or conditions.
No
The device description explicitly states the system uses transmitters and a camera, indicating the presence of hardware components beyond just software.
Based on the provided information, the Orthopilot® 2 Navigation Platform is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Orthopilot® 2 Function: The description clearly states that the Orthopilot® 2 Navigation Platform is a system for computer-aided navigation of surgical instruments within the patient's body during surgery. It uses transmitters and a camera to track the spatial location of instruments and bones in vivo (within a living organism).
- No Sample Analysis: There is no mention of analyzing samples taken from the patient's body. The system directly interacts with the patient's anatomy during the surgical procedure.
Therefore, the Orthopilot® 2 Navigation Platform falls under the category of a surgical navigation system or computer-assisted surgery (CAS) system, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Orthopilot 2 Navigation Platform is a system for computer-aided navigation of surgical instruments. Its purpose is to optimally position endoprosthesis in arthroplasty such as the Search Evolution Knee system and the Gem Knee system in the patient. It aids the surgeon in accurately positioning the cutting guides, drills and reamers for total endoprosthesis replacement surgery and provides intraoperative measurements of bone alignment. It indicates optimized and positions for implant placement. (Does not include an indication for High Tibial Osteotomy (HTO) module).
Product codes
HAW
Device Description
Orthopilot® 2 Navigation Platform uses transmitters that are mounted to the patients bones, or are flexible to palpate landmarks and a camera to monitor the spatial location of those transmitters in relation to each other and the medical instruments. These locations are used to locate the centers of rotation of the femur head, ankle, knee. These measurements allow for greater accuracy than mechanical methods of ascertaining implantation sites and positions.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
femur head, ankle, knee
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Orthopilot® (K003347), Stryker Navigation System-Knee Module (K010204), Brainlab Vector Vision Knee (K010612), Brainlab Vector Vision Hip (K010602)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
K013569 1/2
Orthopilot 2 Navigation Platform
APR 0 4 2002
| Summary of Safety and Effectiveness Information | AESCULAP®, INC. |
|---|---|
| Premarket Notification, Section 510(k) | OCTOBER 23, 2001 |
Regulatory Authority: Safe Medical Devices Act of 1990, 21 CFR 807.92
Trade Name: Orthopilot® 2
Common Name(s): Orthopilot 2 Navigation Platform
Classification Name(s): Stereotaxic Instrument
Establishment Name & Registration Number:
Aesculap®, Inc. Name: Number: 2916714
Classification: 21 CFR Section 882.5550
Device Class: Class II Classification Panel: Neurology Product Code(s): HAW
Applicant Name & Address: Aesculap®, Inc. 3773 Corporate Parkway Center Valley, PA 18034
Company Contact:
Georg Keller Requlatory Affairs Manager 800/258-1946 x 5073 (phone) 610/791-6882 (fax)
Indications for Use
The Orthopilot 2 Navigation Platform is a system for computer-aided navigation of surgical instruments. Its purpose is to optimally position endoprosthesis in arthroplasty such as the Search Evolution Knee system and the Gem Knee system in the patient. It aids the surgeon in accurately positioning the cutting guides, drills and reamers for total endoprosthesis replacement surgery and provides intraoperative measurements of bone alignment. It indicates optimized and positions for implant placement. (Does not include an indication for High Tibial Osteotomy (HTO) module).
Device Description
Orthopilot® 2 Navigation Platform uses transmitters that are mounted to the patients bones, or are flexible to palpate landmarks and a camera to monitor the spatial location of those transmitters in relation to each other and the medical instruments. These locations are used to locate the centers of rotation of the femur head, ankle, knee. These measurements allow for greater accuracy than mechanical methods of ascertaining implantation sites and positions.
1
K015569 2/2
Performance Standards (Section 514 compliance):
No applicable performance standards have been promulgated under Section 514 of the Food, Drug and Cosmetic Act for this device system. However, Aesculap's Orthopilot® 2 Navigation Platform complies with the following standards, which appear, on the FDA List of Recognized Consensus Standards:
- International Electrotechnical Commission; Medical Electrical IEC 60601-1 Equipment, Part 1: General Requirements for Safety.
- International Electrotechnical Commission; Medical Electrical IEC 60601-1-2 Equipment, General Requirements for Safety: Electromagnetic Compatibility - Requirements and Tests.
In addition, the Orthopilot® 2 Navigation Platform meets the requirements of the following Canadian Standard Association standard.
| CAN/CSA- C22.2 | Medical Electrical Equipment, Part 1: General |
|---|---|
| No. 601.1-M90 | Requirements for Safety |
Labeling:
The Aesculap's Orthopilot 2 Navigation Platform discussed in this premarket notification will be manufactured and labeled with the Aesculap® logo. The system will be marketed exclusively to healthcare facilities and physicians.
Substantial Equivalence:
Aesculap's Orthopilot 2 Navigation Platform is substantially equivalent to existing devices cleared by FDA. They are as follows:
- Orthopilot® (K003347) .
- Stryker Navigation System-Knee Module (K010204) .
- Brainlab Vector Vision Knee (K010612) .
- Brainlab Vector Vision Hip (K010602) .
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized symbol that resembles a caduceus, a symbol often associated with healthcare. The symbol is composed of three curved lines that form a shape similar to a bird or a stylized human figure.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Aesculap, Inc. · Mr. Georg Keller Regulatory Affairs Manager 3773 Corporate Parkway Center Valley, Pennsylvania 18034
Re: K013569 Trade Name: Orthopilot 2 Regulation Number: 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: II Product Code: HAW Dated: January 22, 2002 Received: January 23, 2002
APR 0 4 2002
Dear Mr. Keller:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Mr. Georg Keller
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus. permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, (Misbranding by reference to premarket notification( (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 6382041 or (301) 4436597 or at its Internet address HYPERLINK http://www.fda.gov/cdrh/dsma/dsmamain.html http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours.
Miriam C. Provost
For Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
B. INDICATIONS FOR USE STATEMENT
Page 1 of 1
510(k) Number:
Ka13569
Device Name:
Orthopilot® 2 Navigation Platform
Indication for Use:
The Orthopilot® 2 Navigation Platform is a system for computer-aided navigation of surgical instruments. Its purpose is to optimally position endoprosthesis in arthroplasty such as the Search Evolution Knee system and the Gem Knee system in the patient. It aids the surgeon in accurately positioning the cutting guides, drills and reamers for total endoprosthesis replacement surgery and provides intraoperative measurements of bone alignment. It indicates optimized angles and positions for implant placement. (Does not include an indication for High Tibial Osteotomy (HTO) module).
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Muriam C. Phrost
(Division Sign-Off) Division of General, Restorative and Neurological Devices
510(k) Number K013569
or Over-the-Counter Use Prescription Use